225 related articles for article (PubMed ID: 17350787)
1. [New insights into the pathogenesis of ANCA-positive vasculitides].
Guilpain P; Guillevin L; Mouthon L
Presse Med; 2007 May; 36(5 Pt 2):854-9. PubMed ID: 17350787
[TBL] [Abstract][Full Text] [Related]
2. [New aspects in ANCA-associated vasculitides].
Lamprecht P
Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
[TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides.
Csernok E
Autoimmun Rev; 2003 May; 2(3):158-64. PubMed ID: 12848957
[TBL] [Abstract][Full Text] [Related]
4. [Antineutrophil cytoplasmic antibodies].
Sebastiani GD
Reumatismo; 2009; 61(1):69-76. PubMed ID: 19370191
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies.
Reumaux D; Duthilleul P; Roos D
Hum Immunol; 2004 Jan; 65(1):1-12. PubMed ID: 14700590
[TBL] [Abstract][Full Text] [Related]
6. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
7. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides].
Guilpain P; Chanseaud Y; Tamby MC; Mahr A; Servettaz A; Guillevin L; Mouthon L
Presse Med; 2005 Aug; 34(14):1013-22. PubMed ID: 16225257
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenic role of antimyeloperoxidase antibodies].
Guilpain P; Maldini C; Guillevin L
Rev Med Interne; 2011 Jul; 32(7):411-5. PubMed ID: 20633964
[TBL] [Abstract][Full Text] [Related]
11. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
Guillevin L
Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
[No Abstract] [Full Text] [Related]
12. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
13. [Systemic ANCA-associated vasculitis--diagnosis and therapy].
Eisenberger U; Hess C
Ther Umsch; 2008 May; 65(5):295-301. PubMed ID: 18622935
[TBL] [Abstract][Full Text] [Related]
14. Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte maturation in Wegener's granuloma.
Csernok E; Moosig F; Gross WL
Clin Rev Allergy Immunol; 2008 Jun; 34(3):300-6. PubMed ID: 18181035
[TBL] [Abstract][Full Text] [Related]
15. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
16. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
17. L27. Antibodies versus phenotypes: a clinician's view.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):579-82. PubMed ID: 23490640
[No Abstract] [Full Text] [Related]
18. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
Ito-Ihara T; Muso E; Kobayashi S; Uno K; Tamura N; Yamanishi Y; Fukatsu A; Watts RA; Scott DG; Jayne DR; Suzuki K; Hashimoto H
Clin Exp Rheumatol; 2008; 26(6):1027-33. PubMed ID: 19210866
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
